🫀 Lipid Panel Interpretation
Reference cut-offs for TC/LDL/HDL/TG/non-HDL with LDL targets by ASCVD risk and high-triglyceride management. Browser-side reference.
LDL target follows ASCVD risk stratification, which differs slightly by guideline.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
Interpret a lipid panel against the patient's risk level, not a single fixed cut-off.
How it works
LDL targets: very high < 1.4, high < 1.8, moderate < 2.6, low < 3.4 mmol/L. Non-HDL target ≈ LDL target + 0.8 mmol/L.
Key points
- LDL target follows ASCVD risk stratification, which differs slightly by guideline.
- Severe hypertriglyceridaemia (≥ 5.6 mmol/L) prioritises pancreatitis prevention.
- Lp(a) is an independent hereditary risk — measure at least once.
- ApoB reflects atherogenic particle number for residual-risk assessment.
References
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| View | Reference cut-offs |
|---|
→LipidsLipid reference cut-offs (adult, fasting)
- LDL-C：Optimal < 2.6 mmol/L (100 mg/dL); ≥ 3.4 (130) high; ≥ 4.9 (190) very high
- HDL-C：Low: men < 1.0, women < 1.3 mmol/L (< 40 / < 50 mg/dL)
- TG：Desirable < 1.7 mmol/L (150); 1.7–2.3 borderline; ≥ 2.3 high
| View | Special markers/secondary |
|---|
→LipidsSpecial markers / secondary causes
- Lp(a)：Hereditary, independent risk — measure at least once
- ApoB：Reflects atherogenic particle number, better for residual-risk assessment than LDL
- Non-fasting：Usually acceptable; recheck fasting if TG markedly raised or severe hypertriglyceridaemia
Frequently asked questions
- What is Lipid Panel Interpretation?
- Reference cut-offs for TC/LDL/HDL/TG/non-HDL with LDL targets by ASCVD risk and high-triglyceride management. Browser-side reference.
- How is Lipid Panel Interpretation calculated? What is the core formula?
- LDL targets: very high < 1.4, high < 1.8, moderate < 2.6, low < 3.4 mmol/L. Non-HDL target ≈ LDL target + 0.8 mmol/L.
- When is Lipid Panel Interpretation used?
- Interpret a lipid panel against the patient's risk level, not a single fixed cut-off.
- What are the key clinical points for Lipid Panel Interpretation?
- LDL target follows ASCVD risk stratification, which differs slightly by guideline. Severe hypertriglyceridaemia (≥ 5.6 mmol/L) prioritises pancreatitis prevention. Lp(a) is an independent hereditary risk — measure at least once. ApoB reflects atherogenic particle number for residual-risk assessment.
- What are the limits and cautions when using Lipid Panel Interpretation?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is Lipid Panel Interpretation calculated in practice? Can you show a worked example?
- Inputs: View Reference cut-offs → Result: Lipids Lipid reference cut-offs (adult, fasting)（LDL-C: Optimal < 2.6 mmol/L (100 mg/dL); ≥ 3.4 (130) high; ≥ 4.9 (190) very high, HDL-C: Low: men < 1.0, women < 1.3 mmol/L (< 40 / < 50 mg/dL), TG: Desirable < 1.7 mmol/L (150); 1.7–2.3 borderline; ≥ 2.3 high） Inputs: View Special markers/secondary → Result: Lipids Special markers / secondary causes（Lp(a): Hereditary, independent risk — measure at least once, ApoB: Reflects atherogenic particle number, better for residual-risk assessment than LDL, Non-fasting: Usually acceptable; recheck fasting if TG markedly raised or severe hypertriglyceridaemia）